These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 17156651

  • 1. [Efficacy and safety of extended-release niacin alone or with atorvastatin for lipid profile modification].
    Li XP, Duan J, Zhao SP, Tan MY, Xu ZM, Zhang DQ.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 12; 86(34):2399-403. PubMed ID: 17156651
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol.
    Harikrishnan S, Rajeev E, Tharakan JA, Titus T, Ajit Kumar VK, Sivasankaran S, Krishnamoorthy KM, Nair K.
    Indian Heart J; 2008 Sep 12; 60(3):215-22. PubMed ID: 19240310
    [Abstract] [Full Text] [Related]

  • 4. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).
    Bays HE, Dujovne CA, McGovern ME, White TE, Kashyap ML, Hutcheson AG, Crouse JR, ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation.
    Am J Cardiol; 2003 Mar 15; 91(6):667-72. PubMed ID: 12633795
    [Abstract] [Full Text] [Related]

  • 5. Combined use of extended-release niacin and atorvastatin: safety and effects on lipid modification.
    Sang ZC, Wang F, Zhou Q, Li YH, Li YG, Wang HP, Chen SY.
    Chin Med J (Engl); 2009 Jul 20; 122(14):1615-20. PubMed ID: 19719960
    [Abstract] [Full Text] [Related]

  • 6. [Evaluating the efficacy and tolerance of atorvastatin in hyperlipidemia in general practice (SWITCH Study)].
    Noseda G, Darioli R, Keller U, Mordasini R, Shokry A, Schaffhauser B, Riesen W.
    Schweiz Med Wochenschr; 2000 Jun 10; 130(23):889-95. PubMed ID: 10897490
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial of the effects of atorvastatin and niacin in patients with combined hyperlipidemia or isolated hypertriglyceridemia. Collaborative Atorvastatin Study Group.
    McKenney JM, McCormick LS, Weiss S, Koren M, Kafonek S, Black DM.
    Am J Med; 1998 Feb 10; 104(2):137-43. PubMed ID: 9528731
    [Abstract] [Full Text] [Related]

  • 8. [Changes of blood lipids in colorectal cancer patients with coronary heart disease and value of lipid-lowering therapy with statins].
    Liang ZT, Wang XP, Zeng QT, Liao YH, Gao CY, Li MW.
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 May 10; 28(5):863-5. PubMed ID: 18504222
    [Abstract] [Full Text] [Related]

  • 9. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E, Ezetimibe Study Group.
    Am Heart J; 2004 Sep 10; 148(3):447-55. PubMed ID: 15389231
    [Abstract] [Full Text] [Related]

  • 10. A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study.
    Olsson AG, Eriksson M, Johnson O, Kjellström T, Lanke J, Larsen ML, Pedersen T, Tikkanen MJ, Wiklund O, 3T Study Investigators.
    Clin Ther; 2003 Jan 10; 25(1):119-38. PubMed ID: 12637115
    [Abstract] [Full Text] [Related]

  • 11. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
    Wu CC, Sy R, Tanphaichitr V, Hin AT, Suyono S, Lee YT.
    J Formos Med Assoc; 2002 Jul 10; 101(7):478-87. PubMed ID: 12353340
    [Abstract] [Full Text] [Related]

  • 12. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group.
    Clin Ther; 2004 Nov 10; 26(11):1821-33. PubMed ID: 15639694
    [Abstract] [Full Text] [Related]

  • 13. Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia.
    McKenney JM, McCormick LS, Schaefer EJ, Black DM, Watkins ML.
    Am J Cardiol; 2001 Aug 01; 88(3):270-4. PubMed ID: 11472706
    [Abstract] [Full Text] [Related]

  • 14. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias.
    Yee HS, Fong NT.
    Ann Pharmacother; 1998 Oct 01; 32(10):1030-43. PubMed ID: 9793596
    [Abstract] [Full Text] [Related]

  • 15. Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study.
    Athyros VG, Papageorgiou AA, Mercouris BR, Athyrou VV, Symeonidis AN, Basayannis EO, Demitriadis DS, Kontopoulos AG.
    Curr Med Res Opin; 2002 Oct 01; 18(4):220-8. PubMed ID: 12201623
    [Abstract] [Full Text] [Related]

  • 16. Lipid modifying action of atorvastatin in comparison to combination of atorvastatin and nicotinic acid in patients with ischaemic heart disease.
    Santanu G, Suhrita P, Mookerjee S, Tania K, Mita S, Pramit G, Sharmila G, Miraj M, Debdutta M.
    Indian Heart J; 2011 Oct 01; 63(5):434-7. PubMed ID: 23550422
    [Abstract] [Full Text] [Related]

  • 17. [The lipid-regulating effect and safety of combined statin and bezafibrate therapy in acute coronary syndrome patients complicating with dyslipidemia].
    Li XP, Gong HR, Zhao SP, Huang WY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Dec 01; 41(12):1006-9. PubMed ID: 24524601
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study).
    McKenney JM, Jones PH, Bays HE, Knopp RH, Kashyap ML, Ruoff GE, McGovern ME.
    Atherosclerosis; 2007 Jun 01; 192(2):432-7. PubMed ID: 17239888
    [Abstract] [Full Text] [Related]

  • 19. The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin.
    Fonseca FA, Ruiz A, Cardona-Muñoz EG, Silva JM, Fuenmayor N, Marotti M, DISCOVERY PENTA investigators.
    Curr Med Res Opin; 2005 Aug 01; 21(8):1307-15. PubMed ID: 16083541
    [Abstract] [Full Text] [Related]

  • 20. Comparison of efficacy and safety of atorvastatin and simvastatin in patients with dyslipidemia with and without coronary heart disease.
    Karalis DG, Ross AM, Vacari RM, Zarren H, Scott R.
    Am J Cardiol; 2002 Mar 15; 89(6):667-71. PubMed ID: 11897207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.